Study finds molnupiravir well-tolerated, and effective in vaccinated and unvaccinated - News-Medical.Net
Researchers report the phase II efficacy and safety of molnupiravir in both unvaccinated and vaccinated individuals.
Molnupiravir is the first orally-available antiviral treatment that can be administered directly to people with mild-to-moderate coronavirus disease 2019 (COVID-19).
Study: A Randomised -Controlled … [+4452 chars]
Read More
Other Stories in Health
- Smoking linked to higher risk of surgery complications
- Government bans sale and manufacture of 35 fixed-dose combination drugs; full list here
- Many stroke patients with carotid artery narrowing may avoid surgery, research shows
- Internal appetite signals vary with socioeconomic background
- Brown rice may expose young children to unsafe arsenic levels, study finds
- Alarming! Heart attacks caused by sugar and not high cholesterol?
- Chemicals found in mattresses linked to cancer, brain damage: What is the alternative
- Doctors are urging BP patients to have 1 banana daily: 5 reasons to have this superfruit
- Digital lifestyle program cuts diabetes risk by 46% in prediabetics, study of 130k+ adults reveals
.png)
